文献速递功能神经外科

非洲药物难治性癫痫的外科治疗:癫痫发作无发作结局综述

Surgery for Medication Refractory Epilepsy in Africa: A Review of Seizure Freedom Outcomes.
PubMed 文献 · World Neurosurg · 2024-12-29

该综述检索PubMed/MEDLINE、Google Scholar等数据库,最终纳入8篇文章(可能代表7个独特患者队列),评估非洲癫痫外科术后无发作与生活质量结局;约60-100%的患者在术后一年内获得良好无发作结局,并次要性改善生活质量、减轻抑郁严重程度;综述认为在非洲建立并维持癫痫外科项目可行,无发作结局与高收入地区研究报告相当。

要点

  • 非洲每年约211,456例新发个体符合可手术治疗癫痫标准,当前可手术治疗癫痫总量为1,819,067例。
  • 纳入的8篇文章(可能代表7个独特患者队列)显示约60-100%患者术后一年内获得良好无发作结局。
  • 这些队列患者次要性出现生活质量改善和抑郁严重程度减轻。

核心结论

  • 该综述表明在非洲建立并维持癫痫外科项目是可行的,无发作结局与高收入地区研究报告相当。

研究设计与样本

  • 通过PubMed/MEDLINE、Google Scholar数据库检索及已识别文献参考文献回顾,纳入报告非洲癫痫术后无发作和/或生活质量结局的合格研究。
  • 数据库检索检索到超过一千篇文章,17篇全文文章进行合格性审查,最终8篇文章(可能代表7个独特患者队列)纳入本综述。

主要发现

  • 所审查的研究显示癫痫患者外科治疗评估项目成功实施。
  • 这些队列中约60-100%的患者在术后一年内获得良好无发作结局。
  • 这些队列患者次要性出现生活质量改善和抑郁严重程度减轻。

关键数值与推荐

  • 非洲每年约211,456例新发个体符合可手术治疗癫痫标准。
  • 非洲当前可手术治疗癫痫总量为1,819,067例。
  • 约60-100%的患者在术后一年内获得良好无发作结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epilepsy is a chronic condition that confers social stigma, reduced engagement in work and social activities, increased risks of comorbidities, and premature death. It is often treated with medications, but in about a third of patients, epilepsy may be refractory to medications. It is estimated that each year 211,456 new individuals across Africa meet criteria for surgically treatable epilepsy, and the current volume of surgically treatable epilepsy is 1,819,067 cases across the region. Here, we review previously published epilepsy surgery programs in Africa, noting their outcomes. METHODS: Eligible studies reporting seizure freedom and/or quality of life outcomes after epilepsy surgeries conducted in Africa were identified through database searches on PubMed/MEDLINE, Google Scholar, and reviewing references in previously identified publications. RESULTS: While more than a thousand articles were retrieved in the database search, 17 full-length articles were reviewed for eligibility, and 8 articles (likely representing 7 unique patient cohorts) were ultimately included in this study. The reviewed studies demonstrated successful implementation of programs to evaluate patients with epilepsy for surgical treatment. About 60-100% of patients in these cohorts achieved good seizure freedom outcomes within a year from surgery and secondarily had improved quality of life and reduced severity of depression. CONCLUSIONS: This review demonstrates that it is feasible to establish and sustain epilepsy surgery programs in Africa, with seizure freedom outcomes comparable to those reported in studies conducted in parts of the world with higher income.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Antwi P, Padron KB, Ukachukwu AK, et al. Surgery for Medication Refractory Epilepsy in Africa: A Review of Seizure Freedom Outcomes. World Neurosurg. 2024. PMID: 39662623. doi:10.1016/j.wneu.2024.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。